Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early tranexamic acid plus intensive blood pressure control for spontaneous intracerebral hemorrhage
ChiCTR2000036941Phase 4Recruiting
- Sponsor
- Huashan Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid in intracerebral hemorrhage (ICH) (2 arms), sponsored by Huashan Hospital. Primary endpoint: 90-day modified Rankin Scale. Started Oct 2020; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ChiCTR2000036941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036941.